There are three companies in phase 3 trials for Co
Post# of 30027
Thus, Todos is nicely positioned to increase market share and revenue regarding test kits and medical equipment supplies. Taking advantage of current situation, it is nice to hear they are shoring up their future core business in breast cancer detection (and hopefully including Lympro).